LC
XRAY icon

Lindbrook Capital’s Dentsply Sirona XRAY Stock Holding History

Lindbrook Capital’s Portfolio XRAY Stock Details XRAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$55.3K Buy
3,702
+3,200
+637% +$56.7K 0.01% 954
2024
Q4 		$9.53K Sell
502
-1,058
-68% -$22.4K ﹤0.01% 1673
2024
Q3 		$42.2K Buy
1,560
+825
+112% +$21.1K ﹤0.01% 906
2024
Q2 		$18.3K Buy
735
+613
+502% +$17.6K ﹤0.01% 1294
2024
Q1 		$4.05K Buy
122
+48
+65% +$1.64K ﹤0.01% 1990
2023
Q4 		$2.63K Sell
74
-241
-77% -$7.65K ﹤0.01% 2165
2023
Q3 		$10.8K Buy
315
+17
+6% +$646 ﹤0.01% 1375
2023
Q2 		$11.9K Sell
298
-5
-2% -$199 ﹤0.01% 1358
2023
Q1 		$11.9K Sell
303
-22
-7% -$808 ﹤0.01% 1344
2022
Q4 		$10.3K Buy
325
+40
+14% +$1.21K ﹤0.01% 1419
2022
Q3 		$8K Buy
285
+75
+36% +$2.56K ﹤0.01% 1458
2022
Q2 		$8K Buy
210
+1
+0.5% +$40 ﹤0.01% 1375
2022
Q1 		$10K Sell
209
-121
-37% -$6.4K ﹤0.01% 1299
2021
Q4 		$18K Buy
330
+16
+5% +$880 ﹤0.01% 1064
2021
Q3 		$18K Hold
314
– – ﹤0.01% 792
2021
Q2 		$20K Hold
314
– – ﹤0.01% 791
2021
Q1 		$20K Hold
314
– – ﹤0.01% 759
2020
Q4 		$16K Hold
314
– – ﹤0.01% 761
2020
Q3 		$14K Hold
314
– – ﹤0.01% 742
2020
Q2 		$14K Sell
314
-1,365
-81% -$57.7K ﹤0.01% 733
2020
Q1 		$65K Buy
1,679
+190
+13% +$9.68K 0.02% 262
2019
Q4 		$84K Hold
1,489
– – 0.03% 283
2019
Q3 		$79K Sell
1,489
-100
-6% -$5.37K 0.03% 289
2019
Q2 		$92K Buy
1,589
+100
+7% +$5.37K 0.04% 245
2019
Q1 		$73K Buy
1,489
+54
+4% +$2.38K 0.03% 297
2018
Q4 		$53K Buy
+1,435
New +$52.2K 0.03% 325

Other funds holding XRAY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return
NI
Nuance Investments Kansas City, Missouri $588M AUM 6.93% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Lindbrook Capital's XRAY Position: Q1 2025 in Review

Lindbrook Capital increased its Dentsply Sirona (XRAY) stake by 637% in Q1 2025, buying an estimated $56.7K and bringing the position to 3,702 shares worth $55.3K. The position accounts for 0.01% of the portfolio, ranked #954.

Lindbrook Capital first reported a position in XRAY in Q4 2018 and has held it in 26 quarters since. The position peaked at $92K in Q2 2019. 360 funds tracked by Wall St. Rank hold XRAY as of Q1 2025.

  • Lindbrook Capital held 3,702 shares of Dentsply Sirona worth $55.3K as of Q1 2025.
  • Lindbrook Capital bought 3,200 Dentsply Sirona shares in Q1 2025, an estimated $56.7K.
  • Dentsply Sirona made up 0.01% of Lindbrook Capital's portfolio in Q1 2025, its #954 holding.
  • Lindbrook Capital first reported a position in Dentsply Sirona in Q4 2018 and has held it in 26 quarters since.
  • Lindbrook Capital's Dentsply Sirona position peaked at $92K in Q2 2019.
  • 360 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.